{"AllianceGenome": "1786", "HGNC": "1786", "MIM": "600856", "_id": "1028", "_version": 1, "accession": {"genomic": ["AC001228.1", "AC013791.9", "CH471158.1", "CP068267.2", "D64137.1", "KT583840.1", "NC_000011.10", "NC_060935.1", "NG_008022.1", "NT_187585.1", "U48869.1"], "protein": ["AAA85095.1", "AAB05896.1", "AAH67842.1", "ACB69757.1", "BAA11014.1", "BAA11015.1", "EAX02524.1", "EAX02525.1", "NP_000067.1", "NP_001116102.1", "NP_001116103.1", "NP_001349403.1", "NP_001349404.1", "P49918.1"], "rna": ["BC039188.1", "BC067842.1", "BM673714.1", "CD676249.1", "EU570054.1", "NM_000076.2", "NM_001122630.2", "NM_001122631.2", "NM_001362474.2", "NM_001362475.2", "U22398.1"], "translation": [{"protein": "AAA85095.1", "rna": "U22398.1"}, {"protein": "AAH67842.1", "rna": "BC067842.1"}, {"protein": "NP_001349403.1", "rna": "NM_001362474.2"}, {"protein": "NP_001349404.1", "rna": "NM_001362475.2"}, {"protein": "NP_001116103.1", "rna": "NM_001122631.2"}, {"protein": "NP_000067.1", "rna": "NM_000076.2"}, {"protein": "ACB69757.1", "rna": "EU570054.1"}, {"protein": "NP_001116102.1", "rna": "NM_001122630.2"}]}, "alias": ["BWCR", "BWS", "KIP2", "WBS", "p57", "p57Kip2"], "ensembl": [{"gene": "ENSG00000129757", "protein": ["ENSP00000370101", "ENSP00000411257", "ENSP00000411552", "ENSP00000413720", "ENSP00000496631"], "transcript": ["ENST00000380725", "ENST00000414822", "ENST00000430149", "ENST00000440480", "ENST00000471157", "ENST00000647251", "ENST00000681969"], "translation": [{"protein": "ENSP00000413720", "rna": "ENST00000414822"}, {"protein": "ENSP00000411552", "rna": "ENST00000430149"}, {"protein": "ENSP00000411257", "rna": "ENST00000440480"}, {"protein": "ENSP00000370101", "rna": "ENST00000380725"}, {"protein": "ENSP00000496631", "rna": "ENST00000647251"}], "type_of_gene": "protein_coding"}, {"gene": "ENSG00000273707", "protein": ["ENSP00000321019", "ENSP00000484462", "ENSP00000488761", "ENSP00000488786"], "transcript": ["ENST00000313407", "ENST00000616138", "ENST00000631604", "ENST00000631746", "ENST00000633020"], "translation": [{"protein": "ENSP00000488761", "rna": "ENST00000631604"}, {"protein": "ENSP00000484462", "rna": "ENST00000616138"}, {"protein": "ENSP00000321019", "rna": "ENST00000313407"}, {"protein": "ENSP00000488786", "rna": "ENST00000633020"}], "type_of_gene": "protein_coding"}], "entrezgene": "1028", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 1.89781813708, "exp_mis": 107.994018547, "exp_syn": 70.8270508711, "lof_z": 1.36463646981208, "mis_z": 3.62387757574802, "mu_lof": 2.96383957007e-07, "mu_mis": 2.07463769243e-05, "mu_syn": 1.35759151737e-05, "n_lof": 0.0, "n_mis": 31.0, "n_syn": 33.0, "p_li": 0.522821690107795, "p_null": 0.063424078688263, "p_rec": 0.413754231203942, "syn_z": 2.78645697461642}, "bp": 951, "cds_end": 2906719, "cds_start": 2905233, "n_exons": 2, "nonpsych": {"exp_lof": 1.69951527771, "exp_mis": 97.7268177506, "exp_syn": 64.0871350929, "lof_z": 1.28030803956612, "mis_z": 3.55757968928866, "mu_lof": 2.96383957007e-07, "mu_mis": 2.07463769243e-05, "mu_syn": 1.35759151737e-05, "n_lof": 0.0, "n_mis": 28.0, "n_syn": 32.0, "p_li": 0.534327371139856, "p_null": 0.0680452089686039, "p_rec": 0.397627419891541, "syn_z": 2.52353305766565}, "nontcga": {"exp_lof": 1.74421939179, "exp_mis": 99.3527311837, "exp_syn": 65.1591292224, "lof_z": 1.30281201732502, "mis_z": 3.61638637421731, "mu_lof": 2.96383957007e-07, "mu_mis": 2.07463769243e-05, "mu_syn": 1.35759151737e-05, "n_lof": 0.0, "n_mis": 27.0, "n_syn": 32.0, "p_li": 0.517921080497212, "p_null": 0.065305102640515, "p_rec": 0.416773816862273, "syn_z": 2.60098444642093}, "transcript": "ENST00000414822.3"}, "exons": [{"cdsend": 2885489, "cdsstart": 2884003, "chr": "11", "position": [[2883217, 2883915], [2883998, 2884134], [2884669, 2885765]], "strand": -1, "transcript": "NM_000076", "txend": 2885765, "txstart": 2883217}, {"cdsend": 117699, "cdsstart": 116182, "chr": "11_KI270831v1_alt", "position": [[115396, 116094], [116177, 116313], [116879, 117975]], "strand": -1, "transcript": "NM_000076", "txend": 117975, "txstart": 115396}, {"cdsend": 2885456, "cdsstart": 2884003, "chr": "11", "position": [[2883217, 2883915], [2883998, 2884134], [2884669, 2885466], [2885633, 2885775]], "strand": -1, "transcript": "NM_001122630", "txend": 2885775, "txstart": 2883217}, {"cdsend": 117666, "cdsstart": 116182, "chr": "11_KI270831v1_alt", "position": [[115396, 116094], [116177, 116313], [116879, 117676], [117843, 117985]], "strand": -1, "transcript": "NM_001122630", "txend": 117985, "txstart": 115396}, {"cdsend": 2885456, "cdsstart": 2884003, "chr": "11", "position": [[2883217, 2883910], [2883998, 2884134], [2884669, 2885466], [2885633, 2885775]], "strand": -1, "transcript": "NM_001122631", "txend": 2885775, "txstart": 2883217}, {"cdsend": 117666, "cdsstart": 116182, "chr": "11_KI270831v1_alt", "position": [[115396, 116089], [116177, 116313], [116879, 117676], [117843, 117985]], "strand": -1, "transcript": "NM_001122631", "txend": 117985, "txstart": 115396}, {"cdsend": 2885489, "cdsstart": 2884003, "chr": "11", "position": [[2883217, 2883910], [2883998, 2884134], [2884669, 2885775]], "strand": -1, "transcript": "NM_001362474", "txend": 2885775, "txstart": 2883217}, {"cdsend": 117699, "cdsstart": 116182, "chr": "11_KI270831v1_alt", "position": [[115396, 116089], [116177, 116313], [116879, 117985]], "strand": -1, "transcript": "NM_001362474", "txend": 117985, "txstart": 115396}, {"cdsend": 2885456, "cdsstart": 2883773, "chr": "11", "position": [[2883217, 2883910], [2883998, 2884134], [2885201, 2885466], [2885633, 2885775]], "strand": -1, "transcript": "NM_001362475", "txend": 2885775, "txstart": 2883217}, {"cdsend": 117666, "cdsstart": 115952, "chr": "11_KI270831v1_alt", "position": [[115396, 116089], [116177, 116313], [117411, 117676], [117843, 117985]], "strand": -1, "transcript": "NM_001362475", "txend": 117985, "txstart": 115396}], "exons_hg19": [{"cdsend": 2906719, "cdsstart": 2905233, "chr": "11", "position": [[2904447, 2905145], [2905228, 2905364], [2905899, 2906995]], "strand": -1, "transcript": "NM_000076", "txend": 2906995, "txstart": 2904447}, {"cdsend": 2906686, "cdsstart": 2905233, "chr": "11", "position": [[2904447, 2905145], [2905228, 2905364], [2905899, 2906696], [2906863, 2907005]], "strand": -1, "transcript": "NM_001122630", "txend": 2907005, "txstart": 2904447}, {"cdsend": 2906686, "cdsstart": 2905233, "chr": "11", "position": [[2904447, 2905140], [2905228, 2905364], [2905899, 2906696], [2906863, 2907005]], "strand": -1, "transcript": "NM_001122631", "txend": 2907005, "txstart": 2904447}, {"cdsend": 2906719, "cdsstart": 2905233, "chr": "11", "position": [[2904447, 2905140], [2905228, 2905364], [2905899, 2907005]], "strand": -1, "transcript": "NM_001362474", "txend": 2907005, "txstart": 2904447}, {"cdsend": 2906686, "cdsstart": 2905003, "chr": "11", "position": [[2904447, 2905140], [2905228, 2905364], [2906431, 2906696], [2906863, 2907005]], "strand": -1, "transcript": "NM_001362475", "txend": 2907005, "txstart": 2904447}], "generif": [{"pubmed": 8610162, "text": "CDKN1C gene is imprinted, with preferential expression from the maternal allele."}, {"pubmed": 11815601, "text": "Identification and functional characterization of an intragenic DNA binding site for the spumaretroviral trans-activator in the human p57Kip2 gene"}, {"pubmed": 11891335, "text": "Induction of p57(KIP2) expression by p73beta"}, {"pubmed": 11891530, "text": "Down-regulation of p57 may play a role in the dedifferentiation of thyroid carcinoma."}, {"pubmed": 11965547, "text": "DNA methylation and histone deacetylation of p57KIP2 promoter results in gene silencing of p57KIP2 in human tumors"}, {"pubmed": 12239171, "text": "aberrant DNA methylation of the gene occurs in the promoter region in lymphoid malignancies of B-cell phenotype"}, {"pubmed": 12514787, "text": "findings support the hypothesis that misexpression of p57 is involved in the abnormal development of androgenetic complete moles"}, {"pubmed": 12532471, "text": "Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer."}, {"pubmed": 12553041, "text": "P57/KIP2 is a determinant pro-survival factor for cell protection from green tea polyphenol-induced apoptosis."}, {"pubmed": 12586619, "text": "frequently methylated in adult patients with ALL, and that inactivation of a pathway composed of p73, p15, and p57KIP2 predicts for poor prognosis in Ph-negative patients"}, {"pubmed": 12790805, "text": "identified a functional glucocorticoid response element, located 5 kilo bases upstream of the transcription start site in the human p57(Kip2) promoter"}, {"pubmed": 12925736, "text": "SCFSkp2 complex plays an important role in cell-cycle progression by determining the abundance of p57Kip2 and that of the related CDK inhibitor p27Kip1."}, {"pubmed": 12947099, "text": "it is evident that B-Myb protein may promote cell proliferation by a non-transcriptional mechanism that involves release of active cyclin/cyclin dependent kinase 2 from cyclin-dependent inhibitor 1C p57(KIP2)"}, {"pubmed": 12963725, "text": "p57KIP2 modulates stress-activated signaling by functioning as an endogenous inhibitor of JNK/SAPK"}, {"pubmed": 14530263, "text": "p57 may act as a key regulator in embryogenesis by regulating cell cycle through binding to Cdks and the regulating actin dynamics through binding to LIMK-1"}, {"pubmed": 14612924, "text": "loss of p57KIP2 expression appears associated with colorectal carcinogenesis"}, {"pubmed": 14627666, "text": "An epimutation at KvDMR1, the absence of maternal methylation, causes the aberrant silencing of CDKN1C, some 180 kb away on the maternal chromosome."}, {"pubmed": 15007390, "text": "Diminished CDKN1C expression is associated with loss of methylation of CpG & H3K9 at DMR-LIT1, & is involved in esophageal cancer. DMR-LIT1 epigenetically regulates CDKN1C expression through histone modifications at DMR-LIT1 promoter."}, {"pubmed": 15332324, "text": "p57KIP2 was weakly expressed in 4/6 glioblastoma (GBM) specimens by western blot. p57KIP2 immunoreactivity was positive in 8/40 GBMs, and was primarily nuclear in location. The motility of glioma cells was significantly reduced after p57KIP2 induction."}, {"pubmed": 15492797, "text": "Aberrant methylation of p57KIP2 gene is associated with lung and breast cancers and malignant mesotheliomas"}, {"pubmed": 15749785, "text": "p57 is up-regulated in the process of decidualization."}, {"pubmed": 15821902, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15821902, "text": "Variants in CDKN1C may contribute to the inter-individual variation in birth weight."}, {"pubmed": 15888726, "text": "p57KIP2 is part of an imprinted gene network that may play a role in Beckwith-Wiedemann syndrome."}, {"pubmed": 15900410, "text": "endothelial cells of infantile hemangiomas not associated with Beckwith-Wiedemann syndrome normally express p57(KIP2) while chorioangiomas do not"}, {"pubmed": 15936816, "text": "The Cyclin-Dependent Kinase Inhibitor p57 plays key roles in cell cycle regulation, and was methylation-negative in myeloid neoplasia."}, {"pubmed": 15952111, "text": "Transcripts of P57KIP2, imprinted genes related to BWS, were detected in human oocytes and at all stages of preimplantation embryos."}, {"pubmed": 15978938, "text": "The P57 was methylated in 2 (10%) pediatric patients , compared to 20 (37%)respectively in adult patients."}, {"pubmed": 15985436, "text": "identification of a novel p73-Kip2/p57 pathway that coordinates mitotic exit and transition to G1"}, {"pubmed": 16061564, "text": "The absence of methylation and repressive chromatin structure at the CDKN1C promoter in Beckwith-Wiedemann Syndrome patients with loss of methylation at KvDMR1 suggests a direct role of this epimutation in silencing CDKN1C."}, {"pubmed": 16124066, "text": "The decreased expression of p57(kip2) and/or overexpression of cyclinE protein and PCNA may contribute to the occurrence and progression of pancreatic cancer."}, {"pubmed": 16357845, "text": "Methylation of p57(KIP2) may contribute to the malignant progression of gastric MALT lymphomas."}, {"pubmed": 16575194, "text": "Recent advances in epigenetic control of the CDKN1C/KCNQ1OT1 imprinted domain in both humans and mice, causing Beckwith-Wiedemann syndrome and cancer. (review)"}, {"pubmed": 16705184, "text": "Global gene expression analysis in neuroblastoma cells engineered to acutely express the E protein E47 and Id2, showed that p57Kip2 is a target of E47."}, {"pubmed": 16936778, "text": "These results suggest that the tumor suppressive properties of p57KIP2 in leukemia may depend on the intrinsic promoter DNA methylation status of the gene."}, {"pubmed": 16943770, "text": "TGF-beta1 and/or TGF-beta2 inhibit proliferation of primary cultured human limbal epithelial cells, and p57 and p15 play roles in this process."}, {"pubmed": 16950772, "text": "CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene."}, {"pubmed": 17050328, "text": "findings suggest p57kip2 may play a role in the regulation of meiotic progression of early spermatocytes & cell cycle arrest & differentiation of spermatids"}, {"pubmed": 17112701, "text": "These data demonstrate the role of BMP2 compared to BMP6 in the inhibition of growth and induction of differentiation of keratinocytes; p57(Kip2) and p21(Cip1) have a BMP2/6-induced expression."}, {"pubmed": 17351341, "text": "Genetic evidence links the association between DNA-variants in the CDKN1C gene with a risk of atherosclerosis and myocardial infarction."}, {"pubmed": 17351341, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17464323, "text": "mechanism whereby p57(Kip2) influences the mitochondrial apoptotic cell death pathway in cancer cells"}, {"pubmed": 17572845, "text": "In this study, P57kip2 immunostaining was absent in the trophoblastic layers of CHM and was positive in the trophoblast layer of nonmolar villi and MD."}, {"pubmed": 17885492, "text": "We did not find p16, p14, and p57 to be useful as prognostic markers in stage III ovarian cancer"}, {"pubmed": 17986608, "text": "demonstrate that these myoblasts are unable to complete myogenic differentiation because of an inability to up-regulate p57Kip2 transcription"}, {"pubmed": 18325103, "text": "The expression of CDKN1C decreases in the large majority of breast cancers and does not appear to be mediated by AI/LOH at the gene.  CDKN1C may be a breast cancer tumor suppressor."}, {"pubmed": 18430730, "text": "cyclin-dependent kinase inhibitor p57(Kip2) and vascular endothelial growth factor mRNAs are selectively translated by an IRES-independent mechanism under hypoxic stress"}, {"pubmed": 18521080, "text": "miR-221 has an oncogenic function in hepatocarcinogenesis by targeting CDKN1B/p27 and CDKN1C/p57, hence promoting proliferation by controlling cell-cycle inhibitors."}, {"pubmed": 18647205, "text": "The difference in expression patterns of p27(KIP1) and p57(KIP2) in proliferating and senescent melanocytes suggests the interplay between these proteins may play a functional role in melanocytic tumorigenesis"}, {"pubmed": 18676680, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18822693, "text": "p57(Kip2) down-regulation is a well-established feature of urothelial carcinoma. Probably, this down-regulation of cyclin-dependent kinase inhibitors supports the proliferation phase of oncogenesis."}, {"pubmed": 19064572, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19109226, "text": "Detection of epigenetic alterations allows the identification of patients with ALL with standard risk but with poor prognosis."}, {"pubmed": 19116812, "text": "The loss of p57 expression in placental mesenchymal dysplasia could be of diagnostic value in helping to distinguish this rare placental lesion from its mimickers."}, {"pubmed": 19141585, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19145201, "text": "This study validates p57 immunostaining as a prospectively applicable triage assay for the diagnosis of complete hydatidiform mole"}, {"pubmed": 19170196, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19221586, "text": "Results show that the imprinted cell cycle inhibitor CDKN1C is a downstream target for SMARCB1 and is transcriptionally activated by increased histone H3 and H4 acetylation at the promoter."}, {"pubmed": 19340297, "text": "study reveals a novel epigenetic mechanism governing CDKN1C repression in breast cancer. As a newly identified EZH2 target with prognostic value, it has implications in patient stratification for cancer therapeutic targeting EZH2-mediated gene repression"}, {"pubmed": 19386358, "text": "CDKN1C mutations in children born to women with preeclampsia/HELLP syndrome; suggesting the involvement of an imprinted gene in the pathophysiology of preeclampsia"}, {"pubmed": 19453261, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19542869, "text": "We recommend use of p57 immunohistochemistry and molecular genotyping to evaluate all products of conception specimens for which there is any consideration of a diagnosis of hydatidiform mole."}, {"pubmed": 19544095, "text": "KLF4 binds to the p57(Kip2) promoter and transcriptionally upregulates its expression, which in turn inhibits the stress activated protein kinase cascade and c-Jun phosphorylation."}, {"pubmed": 19544458, "text": "Data show that the miRNA miR-92b directly downregulates protein levels of the G(1)/S checkpoint gene p57."}, {"pubmed": 19571260, "text": "Conservation of maternal allele-specific expression of CDKN1C in humans, mice and swine is supported by expression profiling between swine parthenotes and biparental control fetuses."}, {"pubmed": 19590511, "text": "Cyclin-Dependent Kinase Inhibitor p57 repressed Mash1 transcriptional activity, and the interaction with Mash1 as well as the repression of transcriptional activity turned out to be independent of cyclin dependent kinase interactions."}, {"pubmed": 19616848, "text": "methylation of the p57KIP2 gene was analyzed in 63 cases of DLBCL by methylation-specific real-time quantitative PCR. Methylation of the p57KIP2 gene was detected in 53 (84.1%) of these 63 cases of DLBCL"}, {"pubmed": 19625176, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19692168, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19734939, "text": "the p57(Kip2) control of LIMK-1 ultimately affects cell mobility negatively."}, {"pubmed": 20056082, "text": "The degradation of cholesterol didn't affect the level of p57 in cell membrane."}, {"pubmed": 20106982, "text": "CDKN1C negatively regulates RNA polymerase II C-terminal domain phosphorylation in an E2F1-dependent manner"}, {"pubmed": 20484977, "text": "Gene expression pattern of CDKN1C imprinted genes in spontaneous miscarriages or fetal deaths."}, {"pubmed": 20503313, "text": "these findings suggest that Beckwith-Wiedemann syndrome patients with CDKN1C mutations have a different pattern of clinical malformations than those with other molecular defects."}, {"pubmed": 20565244, "text": "High levels of CDKN1C expression are common in human retinoblastoma tumors (RB)."}, {"pubmed": 20626178, "text": "The androgenetic/biparental chimeric Complete Hydatidiform moles demonstrated a negative p57(KIP2)(cyclin-dependent kinase inhibitor 1C) staining pattern for the androgenetic cells and positive staining for the biparental cells"}, {"pubmed": 20634891, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21048031, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 21205084, "text": "EZH2 gene acts as an oncogene in tumorigenesis of ovarian cancer with the possible mechanism to suppress the anti-oncogene p57."}, {"pubmed": 21278784, "text": "MiR-221 binds to the target site in the 3'-UTR of the CDKN1C/p57 mRNA to inhibit CDKN1C/p57 expression by post-transcriptional gene silencing to promote colorectal carcinoma occurrence and progress"}, {"pubmed": 21360479, "text": "expression levels of p57(KIP2) and TGF-beta 1 associated with histological type of lung cancer; expression levels of decorin and p57(KIP2)associated with lymphatic invasion; increased expression of decorin and p57(KIP2) correlated with increased survival"}, {"pubmed": 21371741, "text": "reduced immunostaining of PCNA and Ki67 and increased immunostaining of p27 and p57 in the dexamethasone-induced intrauterine growth restriction placental development compared to control placental development"}, {"pubmed": 21538272, "text": "miR-221 inhibits CDKN1C/P57 expression by post-transcriptional gene silencing to promote colorectal carcinoma development and progression."}, {"pubmed": 21575583, "text": "The different LH subdomains, despite their sequence and thermodynamic differences, play similar roles in binding and inhibiting Cdk2/cyclin A."}, {"pubmed": 21767919, "text": "We confirm that for distinguishing complete hydatidiform mole from its mimics, p57(KIP2) immunohistochemistry can be used as successfully as DNA microsatellite genotyping"}, {"pubmed": 21769918, "text": "Through MEK/ERK pathway, S1P stimulates GAP43 transcription with increased binding of C/EBPbeta to the 5'-promoter tumor cell for metastais"}, {"pubmed": 21816904, "text": "We particularly focus our attention on p57(Kip2) changes in cancers and pharmacological approaches for modulating p57(Kip2) levels."}, {"pubmed": 22002319, "text": "downregulation of p57 accelerates the growth and invasion of HCC, indicating that p57 is an important tumor suppressor in HCC. Based on these findings, p57 may be a potential target for HCC prevention and therapy"}, {"pubmed": 22064387, "text": "Upregulation of p57(kip2) may play an important role in the decidual differentiation by progesterone and growth inhibition of malignant cells in human endometrium."}, {"pubmed": 22079941, "text": "Beckwith-Wiedemann syndrome patients that inherited a maternal translocation or inversion of chromosome 11 also demonstrated reduced expression of the growth suppressing imprinted gene, CDKN1C."}, {"pubmed": 22126772, "text": "MIR221 can interact with the target site on the 3'-UTR of CDKN1C/p57 mRNA to inhibit CDKN1C/p57 expression by post-transcriptional gene silencing to promote colon carcinoma cell proliferation."}, {"pubmed": 22197173, "text": "Case Report: Combination of p57(kip2) immunostaining and HER2 fluorescent in situ hybridization was useful in diagnosing complete hydatidiform mole in a perimenopausal woman."}, {"pubmed": 22205991, "text": "deletion of enhancer elements required for CDKN1C expression lying within or close to the imprinting centre"}, {"pubmed": 22233925, "text": "Cyclin-dependent kinase inhibitor p57(Kip2) is a candidate biomarker of platinum sensitivity/resistance in EOC and such cases may show preferential response to the cyclin-dependent kinase inhibitor seliciclib."}, {"pubmed": 22245958, "text": "Report role of p57 immunohistochemistry and molecular genotyping to improve diagnostic reproducibility of hydatidiform moles."}, {"pubmed": 22292406, "text": "The decreased expression of P57(kip2) and Maspin in abnormal scar shows that they are cicatrix-related genes. There is a positive relationship between the two genes."}, {"pubmed": 22394561, "text": "Signaling through the PI3K (phosphatidylinositol 3-kinase)-Akt-mTOR (mammalian target of rapamycin) pathway was necessary and sufficient for the increase in p57Kip2"}, {"pubmed": 22541097, "text": "Low expression of p57kip2 gene may play a role in the pathogenesis of myelodysplastic syndrome."}, {"pubmed": 22569127, "text": "A novel function was uncovered for p57 that integrates external signals transduced by p38 stress-activated protein kinase to control the cell-cycle, establishing a checkpoint in G1 which is critical to permit cellular adaptation to stress."}, {"pubmed": 22592318, "text": "The p57(KIP2-)mediated stabilization of the actin cytoskeleton was associated with the displacement of hexokinase-1 from the mitochondria, providing a possible mechanism for the promotion of the mitochondrial apoptotic cell death pathway."}, {"pubmed": 22634751, "text": "All IMAGe-associated mutations clustered in the PCNA-binding domain of CDKN1C and resulted in loss of PCNA binding."}, {"pubmed": 22705236, "text": "Down-regulation of Notch1 and Notch3 in two hepatocellular carcinoma cell lines resulted in Hes1 down-regulation, CDKN1C/P57 up-regulation, and reduced cell growth."}, {"pubmed": 22980580, "text": "Co-culture of CB CD34(+) cells with mesenchymal stromal cells, especially in the absence of cytokines, maintained mRNA expression of p21 and p57 genes in ex vivo expanded CD34(+) cells."}, {"pubmed": 22992698, "text": "Report reproducibility of p57 immunohistochemistry and molecular genotyping in the diagnosis of hydatidiform moles."}, {"pubmed": 23008285, "text": "Cdkn1c (p57/KIP2) is a novel regulator of early epidermal differentiation and controls proliferation in primary keratinocytes and HaCaT cells."}, {"pubmed": 23153226, "text": "Based on these findings we conclude that the imprinted gene expression of KCNQ1OT1, CDKN1C, H19, and PLAGL1 are conserved between human and bovine"}, {"pubmed": 23171462, "text": "Downregulation of CDKN1C is associated with poor disease outcome in patients with cutaneous T-cell lymphoma, while upregulation of AHI1 shows a weak association with aggressive disease course."}, {"pubmed": 23187808, "text": "Data suggest that CSN6 is an important negative regulator of p57 (Kip2) , and that overexpression of CSN6 in many types of cancer could lead to decreased expression of p57 (Kip2) and result in promoted cancer cell growth."}, {"pubmed": 23197429, "text": "A novel mutation in CDKN1C was found in a family with Beckwith-Wiedemann syndrome and cleft palate, sensorineural hearing loss, and supernumerary flexion creases."}, {"pubmed": 23244105, "text": "High p57 KIP2 is asociated with breast cancer."}, {"pubmed": 23421998, "text": "These data suggest that HER2/Akt is an important negative regulator of p57 (Kip2), and that p57 restoration in HER2-overexpressing cells can reduce breast tumor growth."}, {"pubmed": 23438793, "text": "The co-expression of p27 and p57 by extravillous cytotrophoblasts and their positive correlation in non-molar gestations may indicate its suppressive role on the proliferation of these cells to provide them the capacity for differentiation and invasion."}, {"pubmed": 23580324, "text": "p15(INK4b) and p57(KIP2) may be involved in the progression of vulvar carcinomas and the combined p14(ARF)/p15(INK4b)/p16(INK4a) status was a statistically independent prognostic factor."}, {"pubmed": 23828667, "text": "p57kip2 appears to be widely expressed in the human oligodendroglial lineage, and potential beneficial effects on remyelination in the mulltiple sclerosis brain are not based on subcellular p57kip2 localization shifts."}, {"pubmed": 23842948, "text": "This study indicates that the abnormal expression of p57 and RhoA contributes to progression of hepatocellular carcinoma and poor survival of patients."}, {"pubmed": 23887308, "text": "p57 expression is highly correlated with genotyping, serves as a reliable marker for diagnosis of complete hydatidiform moles"}, {"pubmed": 23963898, "text": "cell cycle related proteins PCNA, Ki67, cyclin D3, p27 and p57 were expressed in both normal and diabetic human term placentas."}, {"pubmed": 24065356, "text": "A report of a novel mutation of CDKN1C affecting the PCNA-binding domain in a family with a history of Russell Silver syndrome."}, {"pubmed": 24098681, "text": "Increased protein stability of CDKN1C causes a gain-of-function phenotype in patients with IMAGe syndrome."}, {"pubmed": 24613849, "text": "In conclusion, combined p57 immunostaining and FISH with a set of 3 CEP probes for chromosomes X, Y, and 17 could be useful in the classification of hydatidiform moles."}, {"pubmed": 24652995, "text": "p57 regulates T-cell development and prevents lymphomagenesis by balancing p53 activity and pre-TCR signaling."}, {"pubmed": 24848107, "text": "p57 and p21 serve nonredundant functions in trophoblast giant cells; the role of p21 in suppressing apoptosis is restricted to terminally differentiated cells."}, {"pubmed": 24852133, "text": "Staining intensities of cell cycle inhibitors p27 and p57 significantly increased in all parts of preeclamptic placentas compared to control"}, {"pubmed": 24986528, "text": "The gene expression pattern of CDKN1C, H19, IGF2, KCNQ1 and PHLDA2 genes was evaluated using RT-PCR."}, {"pubmed": 25057881, "text": "We report a novel CDKN1C mutation associated with features of IMAGe syndrome, but without adrenal insufficiency or metaphyseal dysplasia, and characterized by early-adulthood-onset diabetes."}, {"pubmed": 25195859, "text": "p57Kip2 has a role in DNA damage response, suppresses tumorigenesis and causes chemoresistance."}, {"pubmed": 25216674, "text": "This report shows that p57(Kip2) is a novel target of miR-21 in prostate cancer and revealing a novel oncogenic function of this microRNA."}, {"pubmed": 25262539, "text": "opposed functional mutations in CDKN1C cause opposite clinical features; loss-of-function mutations cause overgrowth; gain-of-function mutations in the PCNA domain result in growth restriction; only maternally inherited mutations in CDKN1C are associated with disturbed growth [review]"}, {"pubmed": 25339094, "text": "Lefty1 could regulates the cell cycle via modulating the expressions of P57 and cyclin D1 and then inhibit the decidualization in vitro."}, {"pubmed": 25427884, "text": "Data show the presence of maternally derived extra copies of the distal chromosome 11p involving the wild-type cyclin-dependent kinase inhibitor 1C protein (CDKN1C)."}, {"pubmed": 25588980, "text": "Up-regulation of miR-199a-5p in ADPKD tissues might promote cell proliferation through suppressing CDKN1C"}, {"pubmed": 25960208, "text": "downregulation of CDKN1 by siRNA blocked the activity of miR-25 on promoting glioma cell proliferation."}, {"pubmed": 26077438, "text": "CDKN1C sequencing should be performed for BWS patients presenting with abdominal wall defects or cleft palate without 11p15 methylation defects or body asymmetry, or in familial cases of BWS."}, {"pubmed": 26091021, "text": "Using human placental samples, we show that the expression of the imprinted gene CDKN1C associates with birth weight"}, {"pubmed": 26161420, "text": "Polymer-based immunohistochemical staining of p57(kip2) (paternally imprinted gene, expressed from maternal allele) is a very effective method that can be used to differentiate androgenetic complete mole from partial mole and hydropic abortion."}, {"pubmed": 26271467, "text": "Our data indicated that reduced cytoplasmic p57 expression is associated with hepatocellular carcinoma invasion."}, {"pubmed": 26362858, "text": "These results indicate that the inhibitory effect of rapamycin may be due mainly to increased p14, p15, and p57 expression via promoter demethylation and decreased mTOR and p70S6K expression in ALL cell lines."}, {"pubmed": 26606000, "text": "Jab1/Csn5 expression with concurrent low p57 expression associated with poor overall survival in hepatocellular carcinoma"}, {"pubmed": 26857110, "text": "The data has been provided on fetal growth patterns and on the molecular subtypes of Beckwith-Wiedemann syndrome, including gain or loss of DNA methylation, 11p15.5 paternal uniparental disomy, and CDKN1C mutation."}, {"pubmed": 26985855, "text": "The differences in p18(INK4c)and p57(Kip2)activities in chronic myeloid leukemia and normal stem cells suggest a different cell cycle regulation."}, {"pubmed": 27170453, "text": "CDKN1C protein expression in the BM of newly diagnosed, treatment-naive MDS and secondary AML patients was identified as a prognostic factor for poor survival in patients treated with antiproliferative chemotherapy."}, {"pubmed": 27221896, "text": "Low P57KIP2 Expression is associated with Hydatidiform Moles."}, {"pubmed": 27402879, "text": "Data provide evidence that SLC22A18 and/or CDKN1C are tumor modifier genes involved in the tumorigenesis of SDHD-mutated paraganglioma."}, {"pubmed": 27436784, "text": "The mean Beckwith-Wiedemann syndrome (BWS)score was 5.6 for 19 subjects with \"IC2 hypomethylation\"(KCNQ1OT1-associated ), compared with 3.8 for 2 subjects with pUPD. The BWS score of one subject with CDKN1C mutation and one with IC1( H19-associated imprinting center) hypermethylation was 6 and 7, respectively"}, {"pubmed": 27611768, "text": "Analysis of the chromatin status of Cdkn1c promoter and KvDMR1 in unresponsive compared to responsive cell types showed that their differential responsiveness to the MyoD-dependent induction of the gene does not involve just their methylation status but, rather, the differential H3 lysine 9 dimethylation at KvDMR1."}, {"pubmed": 28106536, "text": "Our findings show that the overexpression of p21;{Waf1/Cip1}, down-expression of p57;{Kip2} and gene promoter methylation of p57;Kip2 could be considered as promising diagnostic markers for breast cancer"}, {"pubmed": 28413121, "text": "Expression of CIP/KIP proteins was found abundantly within the proliferative hair matrix, concomitant with a role in cell cycle checkpoint control. p21(CIP1), p27(KIP1) and cyclin E persisted within post-mitotic keratinocytes of the pre-cortex, whereas p57(KIP2) protein decreased but became nuclear."}, {"pubmed": 28508599, "text": "Gain-of-function mutations in the PCNA domain of CDKN1C have been reported as the genetic basis of various growth-retarded syndromes including IMAGe syndrome, Russell Silver syndrome as well as a novel undergrowth syndrome that additionally exhibited early adulthood onset diabetes. {review]"}, {"pubmed": 28574027, "text": "This study showed that negative p57KIP2 immunostaining reliably identified complete mole (CM)and could be used in association with the histological findings to distinguish CM from its mimics."}, {"pubmed": 28803575, "text": "findings showed that pathogenesis of selective intrauterine growth restriction may be related to the co-effect of the up-regulated protein expression of CDKN1C and down-regulated mRNA expression of KCNQ1OT1 in the placenta."}, {"pubmed": 28930539, "text": "Studies indicate that misregulation of p57(kip2) expression has been associated, to growth disorders and the onset of several types of cancers [Review]."}, {"pubmed": 28933484, "text": "SNHG17 exerted oncogenic effects partly through epigenetically silencing P57 expression through interaction with EZH2."}, {"pubmed": 29207083, "text": "expression of the nearby cyclindependent kinase inhibitor 1C (CDKN1C) gene was revealed to be upregulated after SP3 knockdown in cells that possessed non-risk alleles. This suggests that CDKN1C is potentially one of the functional targets of SNP rs163184, which modulates the binding activity of the locus for Sp3 and Lsd1/Kdm1a"}, {"pubmed": 29277274, "text": "Data suggest that expression of CDKN1C and IGF2 is significantly up-regulated in placenta after assisted reproductive technology; DNA methylation was significantly down-regulated in DMR of CDKN1C and up-regulated in DMR of IGF2. (CDKN1C = cyclin-dependent kinase inhibitor-1C; IGF2 = insulin like growth factor 2; DMR = differential methylation regions)"}, {"pubmed": 29295723, "text": "Low p57 expression is associated with Spinal Osteosarcoma Cell Proliferation."}, {"pubmed": 29325014, "text": "P57 is one of the key determinants of endometrial stromal cell differentiation due to its effect on the cell cycle distribution, but its association with the decidua-specific transcription factor needs further investigation."}, {"pubmed": 29428729, "text": "conclusion, our data suggested an essential role of CDKN1C in the tumorgenesis of breast cancer. Targeting CDKN1C may be a promising strategy for anticancer therapeutics."}, {"pubmed": 29511350, "text": "Data identified p57KIP2 as a novel downstream target of TBX3 in PTC and showed that TBX3 represses expression of p57KIP2 through recruiting PRC2 and HDAC1/2 chromatin modification complex."}, {"pubmed": 29614816, "text": "review provides an appraisal of the published data on the p57Kip2 protein; mainly focused on the regulation of CDKN1C (the p57Kip2 encoding gene) expression and its relevance in human diseases, including overgrowth and undergrowth syndromes"}, {"pubmed": 29661169, "text": "If, as expected, the consequences of the deregulation of the CDKN1C-E2F1-TP53 axis were the same as those experimentally demonstrated in mouse models, the disruption of this axis might be useful to predict tumor aggressiveness, and to provide the basis towards the development of potential therapeutic strategies in human Precursor T-cell lymphoblastic lymphomas"}, {"pubmed": 29734178, "text": "The expression of SH3PXD2A-AS1 was inversely correlated with the expression of P57 and KLF2 in Colorectal Cancer tissue samples."}, {"pubmed": 30077532, "text": "CDKN1C is a novel female-specific biomarker of LV function after AMI."}, {"pubmed": 30119259, "text": "HOXD-AS1 could interact with EZH2, and then repress p57 expression, to aggravate osteosarcoma oncogenesis."}, {"pubmed": 30178471, "text": "Through activating the PI3K/AKT/mTOR signalling pathway, p57 can reverse Er/C-225-induced autophagy, and thereby increase the therapeutic efficiency of Er/C-225 treatment in hepatocellular carcinoma."}, {"pubmed": 30544064, "text": "MIRN-92b inhibits p57kip2 expression in hepatocellular carcinoma tissues, thus enhancing the radio-resistance of hepatocellular carcinoma cells to ionizing radiation-based radiotherapy."}, {"pubmed": 30686519, "text": "Studied splicing factor 1 (SF1), insulin like growth factor 2(IGF2), and cyclin dependent kinase inhibitor 1C (p57) as possible prognostic tumor markers in pediatric adrenal cortical tumors. Found SF1 and IGF2 to be highly sensitive in diagnosis and prognosis of pediatric adrenal cortical tumors."}, {"pubmed": 30792202, "text": "this study identified KLF4 as a target gene and a binding partner of RUNX1. KLF4 mediated proliferation inhibition and apoptosis induction of t(8;21) leukemia cells through transactivating P57"}, {"pubmed": 30941985, "text": "Cyclin D1 expression in >10% of positive cells was observed mostly in the clear cell RCC, while p57 expression in </=5% of positive cells was found in 86% of chromophobe RCC specimens. The higher expression of cyclin D1 and lower expression of p57 were more frequent in grade I-II tumors."}, {"pubmed": 31059007, "text": "These results may provide a novel molecular mechanism to understand the involvement of p57KIP2 in the pathogenesis of preeclampsia."}, {"pubmed": 31194812, "text": "Increased CDKN1C and PHLDA2 and reduced IGF-2 abundances in placental tissue were related to BW and early period catch-up growth in full-term SGA infants."}, {"pubmed": 31367252, "text": "CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter."}, {"pubmed": 31497289, "text": "CDKN1C is a key negative regulator of fetal growth. Variants in a very localised \"hot-spot\" cause growth restriction, with or without adrenal insufficiency. However, pathogenic variants in this region are not a common cause of isolated fetal growth restriction phenotypes or loss-of-pregnancy/recurrent miscarriages."}, {"pubmed": 31708464, "text": "ATR-FTIR spectroscopy and CDKN1C gene expression in the prediction of lymph nodes metastases in papillary thyroid carcinoma."}, {"pubmed": 31804259, "text": "Rare clinical findings in three sporadic cases of Beckwith-Wiedemann syndrome due to novel mutations in the CDKN1C gene."}, {"pubmed": 31833013, "text": "Identification of a hydatidiform mole in twin pregnancy following assisted reproduction."}, {"pubmed": 31961825, "text": "Steroid resistance in Diamond Blackfan anemia associates with p57Kip2 dysregulation in erythroid progenitors."}, {"pubmed": 32055942, "text": "the atypical features of hydatidiform moles from patients with recessive NLRP7 mutations and the important relationship between NLRP7 defects in the oocyte and p57 expression that appear to be the main contributor to the molar phenotype regardless of the zygote genotype"}, {"pubmed": 32346031, "text": "The CDK inhibitor p57(Kip2) enhances the activity of the transcriptional coactivator FHL2."}, {"pubmed": 32364515, "text": "Protein and genetic expression of CDKN1C and IGF2 and clinical features related to human umbilical cord length."}, {"pubmed": 32430359, "text": "Improved molecular detection of mosaicism in Beckwith-Wiedemann Syndrome."}, {"pubmed": 32686837, "text": "Androgenetic Complete Hydatidiform Moles With p57KIP2-Positive Immunostaining."}, {"pubmed": 32933137, "text": "Regulation of p27(Kip1) and p57(Kip2) Functions by Natural Polyphenols."}, {"pubmed": 32966862, "text": "USP7 promotes proliferation of papillary thyroid carcinoma cells through TBX3-mediated p57(KIP2) repression."}, {"pubmed": 33046535, "text": "Dephosphorylation of the Proneural Transcription Factor ASCL1 Re-Engages a Latent Post-Mitotic Differentiation Program in Neuroblastoma."}, {"pubmed": 33076988, "text": "Novel mutation points to a hot spot in CDKN1C causing Silver-Russell syndrome."}, {"pubmed": 33360007, "text": "Expression of p57(KIP2) reduces growth and invasion, and induces syncytialization in a human placental choriocarcinoma cell line, BeWo."}, {"pubmed": 33704912, "text": "Investigation of (epi)genotype causes and follow-up manifestations in the patients with classical and atypical phenotype of Beckwith-Wiedemann spectrum."}, {"pubmed": 33792119, "text": "CDKN1C-mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib."}, {"pubmed": 33974722, "text": "Prenatal molecular testing and diagnosis of Beckwith-Wiedemann syndrome."}, {"pubmed": 34018382, "text": "Complementary role of p57kip2 immunostaining in diagnosing hydatidiform mole subtypes."}, {"pubmed": 34065128, "text": "Variable Expressivity of the Beckwith-Wiedemann Syndrome in Four Pedigrees Segregating Loss-of-Function Variants of CDKN1C."}, {"pubmed": 34074808, "text": "Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance."}, {"pubmed": 34272384, "text": "Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer."}, {"pubmed": 34299047, "text": "A Beckwith-Wiedemann-Associated CDKN1C Mutation Allows the Identification of a Novel Nuclear Localization Signal in Human p57(Kip2)."}, {"pubmed": 34464504, "text": "CDKN1C as a prognostic biomarker correlated with immune infiltrates and therapeutic responses in breast cancer patients."}, {"pubmed": 34580843, "text": "High Maternal Serum Estradiol in First Trimester of Multiple Pregnancy Contributes to Small for Gestational Age via DNMT1-Mediated CDKN1C Upregulation."}, {"pubmed": 36037042, "text": "Identification and targeting of a HES1-YAP1-CDKN1C functional interaction in fusion-negative rhabdomyosarcoma."}, {"pubmed": 37212524, "text": "PIK3R3 is upregulated in liver cancer and activates Akt signaling to control cancer growth by regulation of CDKN1C and SMC1A."}, {"pubmed": 37257769, "text": "Promoter methylation and enhanced SKP2 are associated with the downregulation of CDKN1C in cervical squamous cell carcinoma."}, {"pubmed": 37598282, "text": "Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma."}, {"pubmed": 38102140, "text": "MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57[Kip2] targeting."}, {"pubmed": 38151968, "text": "Structure-Function Analysis of p57KIP2 in the Human Pancreatic Beta Cell Reveals a Bipartite Nuclear Localization Signal."}], "genomic_pos": [{"chr": "11", "end": 2885775, "ensemblgene": "ENSG00000129757", "start": 2883213, "strand": -1}, {"chr": "HSCHR11_1_CTG7", "end": 118091, "ensemblgene": "ENSG00000273707", "start": 115392, "strand": -1}], "genomic_pos_hg19": {"chr": "11", "end": 2907111, "start": 2904443, "strand": -1}, "go": {"BP": [{"evidence": "IMP", "gocategory": "BP", "id": "GO:0030511", "pubmed": 16943770, "qualifier": "involved_in", "term": "positive regulation of transforming growth factor beta receptor signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0033673", "pubmed": 19170105, "qualifier": "involved_in", "term": "negative regulation of kinase activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0042326", "pubmed": 19170105, "qualifier": "involved_in", "term": "negative regulation of phosphorylation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0045736", "qualifier": "involved_in", "term": "negative regulation of cyclin-dependent protein serine/threonine kinase activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045892", "pubmed": 19170105, "qualifier": "involved_in", "term": "negative regulation of DNA-templated transcription"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0045893", "pubmed": 19170105, "qualifier": "involved_in", "term": "positive regulation of DNA-templated transcription"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0045930", "qualifier": "involved_in", "term": "negative regulation of mitotic cell cycle"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0050680", "pubmed": 16943770, "qualifier": "involved_in", "term": "negative regulation of epithelial cell proliferation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1904030", "pubmed": 11746698, "qualifier": "involved_in", "term": "negative regulation of cyclin-dependent protein kinase activity"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": 16943770, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": 16943770, "qualifier": "located_in", "term": "cytoplasm"}], "MF": [{"category": "MF", "evidence": "IMP", "id": "GO:0004860", "pubmed": 11746698, "qualifier": "enables", "term": "protein kinase inhibitor activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0004861", "qualifier": "enables", "term": "cyclin-dependent protein serine/threonine kinase inhibitor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [16289477, 18660753, 19170105, 22634751], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0044877", "pubmed": 11746698, "qualifier": "enables", "term": "protein-containing complex binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0140678", "pubmed": 11746698, "qualifier": "enables", "term": "molecular function inhibitor activity"}]}, "homologene": {"genes": [[9544, 721220], [9606, 1028]], "id": 133549}, "interpro": [{"desc": "Cyclin-dependent kinase inhibitor domain", "id": "IPR003175", "short_desc": "CDI_dom"}, {"desc": "Cyclin-dependent kinase inhibitor domain superfamily", "id": "IPR044898", "short_desc": "CDI_dom_sf"}], "ipi": ["IPI00029086", "IPI00216615", "IPI00658048"], "map_location": "11p15.4", "name": "cyclin dependent kinase inhibitor 1C", "other_names": ["cyclin-dependent kinase inhibitor 1C", "cyclin-dependent kinase inhibitor 1C (p57, Kip2)", "cyclin-dependent kinase inhibitor p57"], "pantherdb": {"HGNC": "1786", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "104564", "ortholog_type": "LDO", "panther_family": "PTHR10265", "taxid": 10090, "uniprot_kb": "P49919"}, {"RGD": "727892", "ortholog_type": "LDO", "panther_family": "PTHR10265", "taxid": 10116, "uniprot_kb": "Q69DC1"}, {"ZFIN": "ZDB-GENE-131127-286", "ortholog_type": "O", "panther_family": "PTHR10265", "taxid": 7955, "uniprot_kb": "A0A0R4ITZ5"}, {"ZFIN": "ZDB-GENE-040123-1", "ortholog_type": "LDO", "panther_family": "PTHR10265", "taxid": 7955, "uniprot_kb": "Q6IQT7"}, {"WormBase": "WBGene00000516", "ortholog_type": "O", "panther_family": "PTHR10265", "taxid": 6239, "uniprot_kb": "Q22197"}, {"WormBase": "WBGene00000517", "ortholog_type": "LDO", "panther_family": "PTHR10265", "taxid": 6239, "uniprot_kb": "G5EEJ2"}, {"FlyBase": "FBgn0010316", "ortholog_type": "LDO", "panther_family": "PTHR10265", "taxid": 7227, "uniprot_kb": "Q7JNL9"}], "uniprot_kb": "P49918"}, "pathway": {"kegg": {"id": "hsa04110", "name": "Cell cycle - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1640170", "name": "Cell Cycle"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-453279", "name": "Mitotic G1 phase and G1/S transition"}, {"id": "R-HSA-69231", "name": "Cyclin D associated events in G1"}, {"id": "R-HSA-69236", "name": "G1 Phase"}, {"id": "R-HSA-69278", "name": "Cell Cycle, Mitotic"}, {"id": "R-HSA-9659787", "name": "Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects"}, {"id": "R-HSA-9661069", "name": "Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"}, {"id": "R-HSA-9675126", "name": "Diseases of mitotic cell cycle"}, {"id": "R-HSA-9687139", "name": "Aberrant regulation of mitotic cell cycle due to RB1 defects"}], "wikipathways": [{"id": "WP179", "name": "Cell cycle"}, {"id": "WP2572", "name": "Primary focal segmental glomerulosclerosis (FSGS)"}, {"id": "WP2855", "name": "Dopaminergic Neurogenesis"}, {"id": "WP2880", "name": "Glucocorticoid Receptor Pathway"}, {"id": "WP2882", "name": "Nuclear Receptors Meta-Pathway"}, {"id": "WP3941", "name": "Oxidative Damage"}, {"id": "WP45", "name": "G1 to S cell cycle control"}, {"id": "WP4658", "name": "Small cell lung cancer"}, {"id": "WP474", "name": "Endochondral Ossification"}, {"id": "WP4808", "name": "Endochondral Ossification with Skeletal Dysplasias"}, {"id": "WP4970", "name": "Galanin receptor pathway"}]}, "pfam": "PF02234", "pharmgkb": "PA26320", "pharos": {"target_id": 8821, "tdl": "Tbio"}, "pir": "G02424", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF223811", "relationship": "is"}, {"id": "GNF247255", "relationship": "is"}, {"id": "GNF247256", "relationship": "similar to"}, {"id": "GNF247257", "relationship": "similar to"}, {"id": "GNF247258", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF038929", "relationship": "similar to"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF081414", "relationship": "is"}, {"id": "GNF081415", "relationship": "is"}, {"id": "GNF081416", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051714", "relationship": "is"}, {"id": "GNF056480", "relationship": "is"}, {"id": "GNF061242", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF069769", "relationship": "is"}, {"id": "GNF069770", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF002410", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF098482", "relationship": "is"}, {"id": "GNF138137", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000011.10", "NC_060935.1", "NG_008022.1", "NT_187585.1"], "protein": ["NP_000067.1", "NP_001116102.1", "NP_001116103.1", "NP_001349403.1", "NP_001349404.1"], "rna": ["NM_000076.2", "NM_001122630.2", "NM_001122631.2", "NM_001362474.2", "NM_001362475.2"], "translation": [{"protein": "NP_001349403.1", "rna": "NM_001362474.2"}, {"protein": "NP_001349404.1", "rna": "NM_001362475.2"}, {"protein": "NP_001116103.1", "rna": "NM_001122631.2"}, {"protein": "NP_000067.1", "rna": "NM_000076.2"}, {"protein": "NP_001116102.1", "rna": "NM_001122630.2"}]}, "reporter": {"HG-U133_Plus_2": ["213182_x_at", "213348_at", "216894_x_at", "219534_x_at"], "HG-U95Av2": ["1787_at", "38673_s_at", "39545_at"], "HTA-2_0": ["TC11001284.hg.1", "TC11003009.hg.1"], "HuEx-1_0": "3359432", "HuGene-1_1": "7945767", "HuGene-2_1": "16734475"}, "retired": [702, 64589, 353284], "summary": "This gene is imprinted, with preferential expression of the maternal allele. The encoded protein is a tight-binding, strong inhibitor of several G1 cyclin/Cdk complexes and a negative regulator of cell proliferation. Mutations in this gene are implicated in sporadic cancers and Beckwith-Wiedemann syndorome, suggesting that this gene is a tumor suppressor candidate. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Oct 2010].", "symbol": "CDKN1C", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1366618"}, "unigene": "Hs.106070", "uniprot": {"Swiss-Prot": "P49918", "TrEMBL": ["A0A2R8YFP9", "A6NK88"]}, "wikipedia": {"url_stub": "Cyclin-dependent kinase inhibitor 1C"}}